462 related articles for article (PubMed ID: 8356598)
21. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
Lin SJ; Kuo ML
Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
[TBL] [Abstract][Full Text] [Related]
23. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.
Lauwerys BR; Garot N; Renauld JC; Houssiau FA
J Immunol; 2000 Aug; 165(4):1847-53. PubMed ID: 10925263
[TBL] [Abstract][Full Text] [Related]
24. Role of Natural Killer Cells in Intravenous Immunoglobulin-Induced Graft-versus-Host Disease Inhibition in NOD/LtSz-scidIL2rg(-/-) (NSG) Mice.
Gregoire-Gauthier J; Fontaine F; Benchimol L; Nicoletti S; Selleri S; Dieng MM; Haddad E
Biol Blood Marrow Transplant; 2015 May; 21(5):821-8. PubMed ID: 25596424
[TBL] [Abstract][Full Text] [Related]
25. Role of natural killer cells in the pathogenesis of human acute graft-versus-host disease.
Rhoades JL; Cibull ML; Thompson JS; Henslee-Downey PJ; Jennings CD; Sinn HP; Brown SA; Eichhorn TR; Cave ML; Jezek DA
Transplantation; 1993 Jul; 56(1):113-20. PubMed ID: 8333033
[TBL] [Abstract][Full Text] [Related]
26. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
[TBL] [Abstract][Full Text] [Related]
27. Safety analysis of ex vivo-expanded canine natural killer cells in a xenogeneic mouse model of graft-versus-host disease.
Kim CJ; Park SC; Lee SH; Lim YJ; Yoon M; Park JG; Baek YB; Cho KO; Hong JW; Shin DJ; Kim SK
J Leukoc Biol; 2022 Feb; 111(2):439-450. PubMed ID: 33884654
[TBL] [Abstract][Full Text] [Related]
28. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes.
Melero I; Salmerón A; Balboa MA; Aramburu J; López-Botet M
J Immunol; 1994 Feb; 152(4):1662-73. PubMed ID: 8120376
[TBL] [Abstract][Full Text] [Related]
29. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
30. Antitumor activity, growth, and phenotype of long-term IL-2 cultures of human NK and T lymphocytes.
Fuchshuber PR; Lotzová E; Pollock RE
Lymphokine Cytokine Res; 1991 Apr; 10(1-2):51-9. PubMed ID: 1651770
[TBL] [Abstract][Full Text] [Related]
31. Growth of MCF-7 human breast carcinoma in severe combined immunodeficient mice: growth suppression by recombinant interleukin-2 treatment and role of lymphokine-activated killer cells.
Zhai YF; Esselman WJ; Oakley CS; Chang CC; Welsch CW
Cancer Immunol Immunother; 1992; 35(4):237-45. PubMed ID: 1511458
[TBL] [Abstract][Full Text] [Related]
32. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
[TBL] [Abstract][Full Text] [Related]
33. Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease.
Flanagan DL; Jennings CD; Bryson JS
J Immunol; 1999 Aug; 163(3):1170-7. PubMed ID: 10415011
[TBL] [Abstract][Full Text] [Related]
34. Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency.
Murphy WJ; Conlon KC; Sayers TJ; Wiltrout RH; Back TC; Ortaldo JR; Longo DL
J Immunol; 1993 Apr; 150(8 Pt 1):3634-42. PubMed ID: 8468492
[TBL] [Abstract][Full Text] [Related]
35. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
[TBL] [Abstract][Full Text] [Related]
36. The novel immunomodulator, Linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors.
Condiotti R; Slavin S; Barak V; Nagler A
Leuk Res; 1996 Jan; 20(1):57-63. PubMed ID: 8632678
[TBL] [Abstract][Full Text] [Related]
37. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
Orange JS; Wang B; Terhorst C; Biron CA
J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
[TBL] [Abstract][Full Text] [Related]
38. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells.
Aste-Amezaga M; D'Andrea A; Kubin M; Trinchieri G
Cell Immunol; 1994 Jul; 156(2):480-92. PubMed ID: 7912999
[TBL] [Abstract][Full Text] [Related]
39. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige mice.
Guimarães F; Guven H; Donati D; Christensson B; Ljunggren HG; Bejarano MT; Dilber MS
Leukemia; 2006 May; 20(5):833-9. PubMed ID: 16511516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
